Unnamed: 0,title,date,stock,sentiment
73267.0,"Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial",2020-06-09 06:05:00-04:00,AMPH,positive
73268.0,"BMO Capital Maintains Market Perform on Amphastar Pharmaceuticals, Raises Price Target to $21",2020-05-11 12:07:00-04:00,AMPH,neutral
73269.0,"Amphastar Pharmaceuticals Q1 Adj. EPS $0.170 Beats $0.080 Estimate, Sales $84.688M Beat $82.830M Estimate",2020-05-07 16:27:00-04:00,AMPH,neutral
73270.0,"Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure",2020-04-13 17:20:00-04:00,AMPH,neutral
73271.0,"Amphastar Pharmaceuticals Q4 EPS $0.07 Down From $0.13 YoY, Sales $83.4M Down From $89.69M YoY",2020-03-12 16:32:00-04:00,AMPH,neutral
73272.0,Amphastar Pharma Reports Receives FDA Approval For Supplement Of Abbreviated New Drug Application For Sodium Bicarbonate Injection,2020-02-27 06:14:00-05:00,AMPH,positive
73273.0,"Amphastar Pharmaceuticals Q3 EPS $0.1 Beats $0.07 Estimate, Sales $80.137M Beat $78.53M Estimate",2019-11-07 17:13:00-05:00,AMPH,neutral
73274.0,"Amphastar Pharmaceuticals Q2 EPS $0.08 Beats $0.03 Estimate, Sales $79M Beat $77.61M Estimate",2019-08-07 16:09:00-04:00,AMPH,neutral
73275.0,Momenta Pharma Reports Settlement Deal With Amphastar Resolving Enoxaparin Sodium Injection Litigation,2019-06-19 08:00:00-04:00,AMPH,positive
73276.0,Amphastar Pharma Reports $59.9M Settlement From Momenta/Sandoz Related To Litigation,2019-06-19 06:09:00-04:00,AMPH,negative
73277.0,"Amphastar Pharmaceuticals Q1 EPS $0.1 Beats $0.04 Estimate, Sales $79.79M Beat $76.2M Estimate",2019-05-09 16:22:00-04:00,AMPH,neutral
73278.0,Amphastar Pharmaceuticals Receives FDA Approval For Enoxaparin Sodium Injection 300mg/3mL Multiple Dose Vial,2019-03-19 06:09:00-04:00,AMPH,positive
73279.0,Needham Downgrades Amphastar Pharmaceuticals to Hold,2019-03-13 08:28:00-04:00,AMPH,neutral
73280.0,"Amphastar Pharmaceutical Q4 Adj. EPS $0.13 Beats $0.11 Estimate, Sales $89.69M Beat $78.18M Estimate",2019-03-12 16:29:00-04:00,AMPH,neutral
73281.0,"Stocks Which Set New 52-Week High Yesterday, Wed., Jan. 23, 2019",2019-01-24 10:05:00-05:00,AMPH,neutral
73282.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018",2018-12-04 09:20:00-05:00,AMPH,neutral
73283.0,"Amphastar Pharma Shares Volatile Here, Make Parabolic Move, As Traders Circulate '60 Minutes' Listings For This Weekend",2018-11-16 10:50:00-05:00,AMPH,positive
73284.0,"Amphastar Pharmaceuticals Q3 EPS $0.12 Beats $0.11 Estimate, Sales $75.543M Beat $74.73M Estimate",2018-11-08 17:26:00-05:00,AMPH,neutral
73285.0,"Hearing Wells Fargo Out Positive On Amphastar Pharmaceutics, Says Believes Primatene Mist Approval Could Add At Least $4-$6 In Value Per Share; Unconfirmed",2018-11-08 09:50:00-05:00,AMPH,positive
73286.0,"Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc., Raises $57M In A Private Placement",2018-07-09 06:01:00-04:00,AMPH,neutral
73287.0,"Amphastar Reports Approval for Isoproterenol Hydrochloride Injection, USP; Anticipates Launching Product In Q3 2018",2018-06-19 06:00:00-04:00,AMPH,positive
73288.0,Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals,2018-06-04 06:00:00-04:00,AMPH,positive
73289.0,Form 4 Filing Late Thursday Showed Amphastar Pharmaceuticals CEO Jack Zhang Bought a Total of 40K Shares at Avg. Prices Ranging From $15.76 to $16.50,2018-05-18 10:22:00-04:00,AMPH,positive
73290.0,Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection,2018-05-14 06:02:00-04:00,AMPH,positive
73291.0,"Amphastar Pharmaceuticals Announces Resubmission Of NDA For Primatene After Receiving ""Good"" Results From Human Factors Study; Co. Does Not Have PDUFA Date Yet",2018-05-09 17:24:00-04:00,AMPH,neutral
73292.0,"Amphastar Pharmaceuticals Q1 EPS $(0.05) Misses $0.08 Estimate, Sales $58.39M Miss $60.75M Estimate",2018-05-09 17:21:00-04:00,AMPH,negative
73293.0,Amphastar  Pharmaceuticals Says U.S.  District Court Entered Final Judgement In Favor Of Co. In A Lawsuit Brought By Momenta Pharmaceuticals,2018-03-21 06:02:00-04:00,AMPH,positive
73294.0,"Amphastar Pharmaceuticals Reports Q4 EPS $0.10 vs $(0.02) Est., Sales $60.4M vs $60M Est.",2018-03-12 16:08:00-04:00,AMPH,neutral
73295.0,"Amphastar Announces FDA Approval for Sodium Nitroprusside Injection, USP",2017-12-19 06:00:00-05:00,AMPH,positive
73296.0,Amphastar Announces FDA Approval Of Two Medroxyprogesterone Acetate Injectable Suspension ANDAs,2017-11-29 14:50:00-05:00,AMPH,positive
73297.0,Raymond James Downgrades Amphastar Pharmaceuticals to Market Perform,2017-11-09 07:50:00-05:00,AMPH,neutral
73298.0,"Amphastar Pharma Reports Q3 Adj. EPS $0.07 from $0.14 YoY, Sales $57.92M From $64.22M YoY",2017-11-08 16:38:00-05:00,AMPH,neutral
73299.0,Amphastar Pharmaceuticals Receives FDA Approval For Sodium Bicarbonate Injection,2017-09-20 16:22:00-04:00,AMPH,positive
73300.0,"Amphastar Pharmacueitclas Reports Q2 Adj. EPS $0.11 vs $0.23 In Same Qtr. Last Year, Sales $65.2M May Not Compare To $19.49M Est.",2017-08-09 16:14:00-04:00,AMPH,neutral
73301.0,Amphastar Pharma Wins Patent Infringement Trial Against Momenta Pharma,2017-07-24 06:04:00-04:00,AMPH,positive
73302.0,"UPDATE: Momenta Pharma Issues Release Confirming Earlier Reports Of Court Ruling In Favor Or Amphastar Pharma In Generic Lovenox Patent Case; Co. Says Its Patent Was Infringed, But Found To Be Invalid And Unenforceable",2017-07-21 14:22:00-04:00,AMPH,positive
73303.0,U.S. Jury Clears Amphastar Pharmaceuticals inc In Patent Lawsuit By Momenta Pharmaceuticals Inc,2017-07-21 12:34:00-04:00,AMPH,negative
73304.0,"Amphastar Pharmaceuticals Reports Q1 Adj. EPS $0.09 vs $0.12 In Same Qtr. Last Yar, Sales $56.670M vs $59.366M YoY",2017-05-08 17:19:00-04:00,AMPH,neutral
73305.0,"Amphastar Pharmaceuticals Reports Q3 Adj. EPS $0.09 vs $0.12 In Prior Year Quarter, Sales $56.67M vs $59.36M In Prior Year Quarter",2017-05-08 16:07:00-04:00,AMPH,neutral
73306.0,CVS Announces Availability Of Amphastar's Naloxone At All Iowa Locations,2017-03-29 17:23:00-04:00,AMPH,neutral
73307.0,"Raymond James Downgrades Amphastar Pharmaceuticals To Outperform, Lowers Price Target To $18",2017-03-14 09:00:00-04:00,AMPH,negative
73308.0,"Amphastar Pharma Reports Q4 Adj. EPS $0.01 vs $(0.01) Est., Sales $63.5M vs $55.8M Est.",2017-03-13 16:23:00-04:00,AMPH,neutral
73309.0,Amphastar Pharma Complete Response Letter from FDA Says Company Should Conduct Human Factor Validation Study and Make Label Changes,2016-12-27 06:01:00-05:00,AMPH,neutral
73310.0,BMO Capital Initiates Coverage on Amphastar Pharmaceuticals at Market Perform,2016-06-29 06:26:00-04:00,AMPH,neutral
73311.0,Wells Fargo Initiates Coverage on Amphastar Pharmaceuticals at Outperform,2016-02-19 08:40:00-05:00,AMPH,positive
73312.0,Amphastar Pharmaceuticals Launches Amphadase,2015-10-20 06:06:00-04:00,AMPH,neutral
73313.0,"Raymond James Initiates Coverage on Amphastar Pharmaceuticals at Strong Buy, Announces $23.00 PT",2015-06-03 06:31:00-04:00,AMPH,positive
73314.0,"Amphastar Pharmaceuticals Reports Q3 EPS of $(0.07), Down 240% YOY; Revenue of $59.70M, Up 1% YOY",2014-11-12 16:07:00-05:00,AMPH,neutral
73315.0," Amphastar Pharmaceuticals Reports Q2 EPS of $0.02, Down 98% YOY; Revenue of $49.0M vs $19.49M Est",2014-08-12 16:12:00-04:00,AMPH,neutral
73316.0,"BMO Capital Initiates Coverage on  Amphastar Pharmaceuticals at Outperform, Announces $17.00 PT",2014-07-21 07:34:00-04:00,AMPH,neutral
73317.0,"Needham Initiates Coverage on  Amphastar Pharmaceuticals at Buy, Announces $17.00 PT",2014-07-21 07:33:00-04:00,AMPH,neutral
73318.0,"Piper Jaffray Initiates Coverage on  Amphastar Pharmaceuticals at Overweight, Announces $18.00 PT",2014-07-21 07:33:00-04:00,AMPH,negative
73319.0,"Jefferies Initiates Coverage on  Amphastar Pharmaceuticals at Buy, Announces $14.00 PT",2014-07-21 07:32:00-04:00,AMPH,neutral
73320.0,Wunderlich Has $64 Target On ProAssurance Corp. (PRA),2010-12-14 08:47:00-05:00,AMPH,neutral
73321.0,American Physicians is Acquired - Analyst Blog,2010-12-01 18:00:00-05:00,AMPH,neutral
73322.0,American Physicians is Acquired - Analyst Blog,2010-12-01 12:15:00-05:00,AMPH,neutral
73323.0,ProAssurance Completes Acquisition of APS for $32.50,2010-11-30 16:07:00-05:00,AMPH,neutral
73324.0,American Physicians Beats Estimates - Analyst Blog,2010-11-04 14:33:00-04:00,AMPH,neutral
73325.0,Oppenheimer Removes Rating On AMPH,2010-09-28 08:49:00-04:00,AMPH,neutral
73326.0,AMPH Redeems Preferred Stock - Analyst Blog,2010-09-07 15:36:00-04:00,AMPH,neutral
73327.0,American Phys. Goes to ProAssurance - Analyst Blog,2010-09-06 08:33:00-04:00,AMPH,neutral
73328.0,"Benzingaâ€™s Top Downgrades (PPL, VALE, AMPH, MNRO)",2010-09-02 10:09:00-04:00,AMPH,positive
73329.0,"NASDAQ Stocks Hitting 52-Week Highs (ARUN, SLRY, TIBX, AMPH)",2010-09-01 13:21:00-04:00,AMPH,neutral
73330.0,PRA Agrees To Buy AMPH; Shares Climb,2010-09-01 11:17:00-04:00,AMPH,positive
73331.0,"Mid-Day Market Movers (SLRY, SRZ, AMPH, PTSX)",2010-09-01 10:46:00-04:00,AMPH,neutral
73332.0,"ProAssurance to Acquire American Physicians Service Group  (PRA, AMPH)",2010-09-01 09:16:00-04:00,AMPH,neutral
73333.0,American Physicians Upgraded - Analyst Blog,2010-08-27 12:54:00-04:00,AMPH,neutral
73334.0,Zacks #1 Rank Additions for Thursday  - Tale of the Tape,2010-08-05 08:53:00-04:00,AMPH,neutral
73335.0,American Physicians Service Group (AMPH) Maintains Outperform Rating,2010-03-02 09:49:00-05:00,AMPH,neutral
